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A PCR using primers aimed at the multicopy gene coding for the small subunit rRNA and resulting in the
synthesis of a 180-bp fragment was evaluated for its use in diagnosing invasive candidiasis in comparison with
blood culture. With the use of a C. albicans-specific probe, 610 to 15 C. albicans cells are detected in 100 ml of
whole blood by Southern analysis. A DNase pretreatment was critical in the purification process of yeast DNA
from whole blood. Omission of the DNase pretreatment decreased assay sensitivity 10-fold. PCR analysis of
blood specimens collected from mice with invasive candidiasis is more sensitive than blood culture (100 versus
67%, respectively) at 72 h after intravenous (i.v.) inoculation with C. albicans. Furthermore, the intensity of the
hybridization signals increased with the progression of infection. In contrast, multiple blood samples from
gastrointestinally colonized mice were all negative by PCR, indicating that the PCR assay is also specific and
may, therefore, make a positive contribution to the detection and follow-up of invasive candidiasis.
The opportunistic pathogen Candida albicans is able to
cause disseminated infections in immunocompromised pa-
tients. To reduce mortality in patients with invasive candidiasis,
early initiation of antifungal drug therapy is critical (1). The
clinical diagnosis is complicated because C. albicans commonly
colonizes or causes mild infection of the mucous membranes
or skin. It is, therefore, often difficult to judge the clinical
significance of the finding of C. albicans in secretions or on the
body surfaces when systemic infection is suspected in the case
of occult fever or for other reasons. Microbiological evidence
for the diagnosis of invasive candidiasis requires the demon-
stration of C. albicans in sterile body fluids, biopsies, or mul-
tiple consecutive blood cultures (7). There are, however, many
problems inherent in these tests (12). Berenguer et al. (2), for
instance, recently demonstrated that even by application of the
lysis-centrifugation technique, a sensitivity of only 43% was
established in autopsy-proven cases of invasive candidiasis.
They also demonstrated that the sensitivity of the lysis-centrif-
ugation blood culture technique correlated with the number of
infected tissue sites, and therefore, these investigators stressed
the need for more sensitive methods for detection of invasive
candidiasis.
Since PCR has proven to be a powerful tool in the early
diagnosis of several infectious diseases, it might also be a more
sensitive alternative assay in the diagnosis of invasive candidi-
asis. Several PCR methods for the detection of Candida spp. in
patient materials have been published (3, 6, 8, 10). However,
the diagnostic usefulness of PCR remains to be established
because of the reported limitations of the technique when
whole blood is used (6, 8), the lack of verification with a
species-specific probe for the amplified product (3), and the
inability to detect medically important Candida spp. other than
C. albicans (11).
The efficacy of application of PCR in the early diagnosis of
systemic candidiasis has to be ascertained in comparison with
that of the blood culture technique, and furthermore, PCR
results must be negative in patients who are merely colonized
with C. albicans. In the present study, the diagnostic usefulness
of PCR was studied by detecting C. albicans in whole blood of
systemically infected mice and in gastrointestinally colonized
mice in order to determine the sensitivity and accuracy of the
PCR assay for discriminating between colonization and inva-
sive candidiasis.
(Part of this manuscript was presented at the Conference on
Candida and Candidiasis: Biology, Pathogenesis and Manage-
ment, Baltimore, Md., 25 to 28 March 1993 [poster presenta-
tion abstract number, A/9].)
MATERIALS AND METHODS
Animals and Candida strain. Specific-pathogen-free, 11- to 13-week-old fe-
male BALB/c mice weighing 622 g were used (Iffa Credo, L’Arbresle, France).
C. albicans (ATCC 44858) was used throughout all the experiments. The yeast
was stored at 2808C in Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.)
containing 10% (vol/vol) glycerol. Stationary-growth-phase cultures were ob-
tained after incubation of the yeast in Sabouraud maltose broth (Difco Labora-
tories) for 24 h at 378C. The yeasts were washed in phosphate-buffered saline
(PBS), counted in a hemocytometer, and adjusted to 53 104 cells per ml in PBS.
Systemic infection in neutropenic mice. Neutropenia was induced by intraper-
itoneal administration of cyclophosphamide (Sigma) at 100 mg/kg of body weight
4 days prior to inoculation with C. albicans, followed by additional doses of 75
mg/kg on the day of inoculation and at 3-day intervals during the course of
infection (14). This treatment resulted in persistent granulocytopenia of ,100
granulocytes per ml of blood from the time of inoculation with C. albicans up to
termination of the studies. In each experiment 21 neutropenic mice were infected
by inoculation of 200 ml of 5 3 104 CFU of C. albicans per ml in the tail vein.
At 1, 6, 24, 48, 72, 96, and 144 h after inoculation with C. albicans, the mice
were sacrificed, using three mice for each time point. At the above-indicated time
intervals, blood was collected in EDTA-coated tubes by cardiac puncture. Of
each blood sample, 100 ml was directly cultured on Sabouraud dextrose agar
(SDA) plates (Oxoı¨d, Basingstoke, England) and incubated for 5 days at 378C.
Another 100 ml of blood was used for DNA extraction.
The kidneys, spleen, liver, and lungs were removed from each mouse and
separately homogenized in 20 ml of PBS for 30 s at 10,000 rpm in a VirTis
homogenizer (VirTis Co. Inc., Gardiner, N.Y.). Two hundred microliters of the
serial twofold dilutions of each homogenate was plated on SDA plates. The
remainder of the homogenate, together with an equal volume of double-strength
SDA, was mixed and poured into petri dishes. All plates were incubated for 48
h at 378C.
Gastrointestinal colonization in immunocompetent mice.Gastrointestinal col-
onization was established by pretreating mice for 5 days with cefradine (1 g/liter,
Velosef 250; Bristol Myers-Squibb, Woerden, The Netherlands). Cefradine was
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added to their drinking water throughout the experiment. Inoculation with 1.107
CFU of C. albicans was performed by gastric intubation. Feces were collected
and cultured, at 2-day intervals. The mice were sacrificed 8 days after inoculation
with C. albicans. Blood was sampled by cardiac puncture and collected into
EDTA-coated tubes. One hundred microliters of blood was directly subcultured
on SDA plates, and 100 ml of whole blood was used for DNA extraction. Kidneys,
lungs, liver, and spleen as well as stomach and gastrointestinal tract were re-
moved, homogenized, and cultured as described above.
PCR sample preparation. For Candida DNA extraction from blood we used a
method modified from Buchman et al. (3). Briefly, 0.1 ml of lysis buffer (0.32 M
sucrose, 10 mM Tris-HCl [pH 7.5], 5 mM MgCl2, 1% Triton X-100) was added
to 0.1 ml of whole blood. After lysis, cell debris and Candida yeast cells were
pelleted by centrifugation (Eppendorf; Merck, Amsterdam, The Netherlands) at
16,000 3 g for 5 min. The pellet was resuspended in 0.2 ml of lysis buffer. To
remove free, non-yeast cell DNA, 7 ml of DNase (10 mg/ml; Boehringer GmbH,
Mannheim, Germany) was added and the samples were incubated at 378C for 1
h. After centrifugation at 16,000 3 g for 5 min, the pellets were resuspended in
0.2 ml of TEG buffer (50 mM glucose, 25 mM Tris-HCl [pH 8.0], 10 mM EDTA)
containing 1.5 ml of Lyticase (900 U/ml; Sigma Chemical Co., St. Louis, Mo.) and
incubated for a further 1 h at 378C. Subsequently, 3.0 ml of pronase (15 mg/ml;
Boehringer GmbH) and 10 ml of 10% sodium dodecyl sulfate (SDS) were added
and further incubated for 1 h at 378C. DNA extraction and purification was
realized by using Prep-A-gene DNA matrix according to the instructions of the
manufacturer (Bio-Rad Laboratories, Richmond, Calif.). The matrix was eluted
with 40 ml of TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA).
Filter tips (Biozym, Landgraaf, The Netherlands) were used throughout the
isolation procedure to avoid contamination.
Primers and PCR protocol. PCR was performed on 10 ml of the DNA samples,
which corresponded to 25 ml of the original blood sample. The following primer
set, generating a 180-bp fragment spanning the V4 region of the small subunit
rRNA gene, was used: 532 (59-TATTAAAGTTGTTGCAG-39) and 651 (59-
CCTGCTTTGAACACTCTAATTT-39) (13). PCR was performed in 100 ml of
PCR solution containing 50 mM KCl, 10 mM Tris HCl (pH 8.3), 2.5 mMMgCl2,
200 mM (each) dNTP, 50 pmol of each primer, 0.1 mg of gelatin per ml, 1 U of
Taq DNA polymerase (Promega, Leiden, The Netherlands), and 10 ml of sample
specimen. The reaction mixture was overlaid with 100 ml of mineral oil (Sigma)
to prevent evaporation and was preincubated for 5 min at 948C for DNA dena-
turation. Forty cycles of amplification were performed with a PCR processor
(Biomed GmbH, Theres, Germany). Each cycle consisted of a denaturation step
at 948C for 1 min, a primer-annealing step at 528C for 1.5 min, and a chain-
elongation step at 748C for 1 min. After 40 cycles, a temperature-delay step of 5
min at 748C completed elongation. Thirty microliters of the amplified PCR
product was analyzed by agarose (1.5%, wt/vol) gel electrophoresis.
Southern blot analysis of PCR products. DNA was transferred from agarose
to Hybond Plus nylon filters (Amersham International, plc, Amersham, United
Kingdom) by overnight diffusion blotting in 0.4 N NaOH. The PCR products
were analyzed with the C. albicans-specific probe (59-GTAGCCATTTATGGC
GAACC-39) (13). The membranes were preincubated at 378C in a hybridization
solution (53 SSC [13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 13
Denhardt’s solution) for 1 h. Hybridization occurred overnight at 378C with 20
pmol of T4 polynucleotide kinase (Life Technologies, Ltd., Renfrewshire, Scot-
land) [g-32P]ATP (3,000 Ci/mmol; Amersham)-labelled oligonucleotide probe.
The filters were washed once for 15 min at 378C and once for 15 min at 558C with
23 SSC–0.1% (wt/vol) SDS. Autoradiography was performed with Kodak Royal
X-Omat film and a 3.5-h exposure time.
RESULTS
PCR sensitivity. In order to develop a test with a better
sensitivity than that of blood culture, special effort was put into
determining the method of DNA extraction and into creating
optimal storage conditions for the blood samples. As a guide-
line for the DNA extraction, the method described by Buch-
man et al. (3) was used. An essential step in the DNA extrac-
tion procedure proved to be the digestion of non-yeast DNA
by DNase pretreatment. Figure 1 shows the results of making
a 10-fold dilution series of C. albicans in whole sheep blood
and performing the DNA extraction with and without DNase
pretreatment. By application of DNase pretreatment we were
able to detect 10 to 15 cells of C. albicans per 100 ml of whole
blood. Leaving out the DNase treatment, only 150 to 200 cells
of C. albicans per 100 ml could be detected, thus reducing the
sensitivity of the PCR assay at least 10-fold.
Before starting the in vivo experiments, several conditions
were studied with regard to the storage of blood samples for
PCR analysis. Several blood samples were spiked with a 10-
fold dilution series of C. albicans in whole sheep blood, and the
following three procedures were tested: (i) direct extraction by
the standard procedure, (ii) partial processing of the samples
up to the pronase treatment step and subsequent completion
of the rest of the standard protocol 1 week later after the
samples had been kept at 2208C, and (iii) freezing of the
samples at 2208C for 1 week and subsequent extraction of
DNA by the standard protocol. We found that direct extraction
or partial processing incurs no loss in reproducibility or sensi-
tivity. However, freezing the blood samples at 2208C for 1
week prior to DNA processing was associated with some loss of
reproducibility and sensitivity of the PCR assay (Fig. 2). We
therefore decided to routinely process the blood samples ob-
tained in the in vivo experiments with the two-stage extraction
procedure, i.e., procedure (ii), so that all samples belonging to
one in vivo experiment could be processed in a single PCR.
Systemically infected mice. To test the sensitivity and in vivo
accuracy of the Candida PCR assay, we used an induced sys-
temic C. albicans infection in mice with cyclophosphamide-
induced neutropenia. Since cyclophosphamide is metabolized
in the liver into metabolites which actively cross-link DNA
chains, control experiments were performed to check whether
blood containing active cyclophosphamide metabolites would
interfere with the PCR. Therefore, purified C. albicans DNA
was added to blood, collected from mice 1 and 6 h after they
had received intraperitoneal cyclophosphamide, and incubated
at 378C. At 15, 30, and 60 min of incubation, samples were
taken and the DNA was extracted and assayed by PCR. From
these experiments it was concluded that active cyclophospha-
mide metabolites did not interfere with the Candida PCR assay
of whole blood (data not shown).
FIG. 1. Southern blot analysis of C. albicans PCR products in whole sheep
blood with (A) and without (B) DNase pretreatment. Lanes: 1 through 5, C.
albicans cells spiked at 2,300, 230, 115, 23, and 0 (negative control) per 100 ml of
whole blood, respectively.
FIG. 2. Sensitivity and reproducibility results of the C. albicans PCR assay
conducted with whole sheep blood processed by three different procedures:
direct testing after DNA extraction by the standard procedure (A), partial pro-
cessing of the samples up to the pronase treatment step and subsequent com-
pletion of the rest of the standard protocol 1 week later after the samples had
been kept at 2208C (B), and freezing of the samples at 2208C for 1 week and
subsequent extraction and testing according to the standard protocol (C). Lanes:
1 through 5, C. albicans DNA from 3,000, 300, 150, 30, and 10 cells per 100 ml
of whole blood, respectively; lanes 6 and 7 are negative controls. Lane 6, 100 ml
of processed blood sample; lane 7, 100 ml of sterile PBS (both lanes without
spiked Candida cells).
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After the mice were i.v. challenged with 104 CFU of C.
albicans, the mean number of CFU per organ increased (kid-
ney) or remained more or less constant (lung, liver, and
spleen) over the course of the experiment (Fig. 3). The infec-
tion model is reproducible since the number of CFU per organ
remained in the same order of magnitude (Fig. 3). The results
of the blood cultures and PCR are given in Table 1. Blood
culture results varied considerably and showed CFU counts
ranging from 0 to 45 CFU per 100 ml of blood. Early after the
onset of the infection as well as at 72 h into the infection, blood
cultures tended to yield higher numbers of CFU. At 24 and 48
h, the CFU counts were often lower than at 1 and 72 h. In Fig.
4, PCR results of the blood samples from each mouse, from
experiments 1 and 3, indicate that with the progression of the
infection more DNA targets became available for amplifica-
tion. However, this increase in PCR signal did not correlate
with the number of CFU of C. albicans cultured from the same
blood sample (Table 1). This difference in the sensitivities of
the PCR assay and blood culture was scored at each sampling
moment (Table 1). PCR was more often positive at 48 and 72
h and has, therefore, a better sensitivity than blood culture. In
only one blood sample, C. albicans was cultured (1 CFU per
100 ml) but no PCR signal could be obtained (experiment 2; 24
h).
Gastrointestinal colonization of mice. From the previous
results we concluded that the PCR assay may be more sensitive
than blood culture for the detection of systemic C. albicans
infection. To gain insight into the ability of the PCR assay to
accurately discriminate between colonization and invasive can-
didiasis, a model for gastrointestinal-tract C. albicans coloni-
zation in mice was established.
After inoculation of six mice with 107 CFU of C. albicans,
feces were cultured from the animals at days 2, 4, and 6. Feces
cultures grew C. albicans in a yield of 14 to 1,500 CFU per mg
of feces. In contrast, feces samples of cefradine-treated mice
before inoculation were all negative for C. albicans.
Eight days after inoculation with C. albicans, the mice were
sacrificed and several organs were cultured. The stomach and
gastrointestinal tract grew C. albicans in each case. In contrast,
kidneys, liver, lungs, and spleen were always sterile. Cultures of
blood samples obtained at day 8 via cardiac puncture were all
negative, as were the results of PCR with the same blood
samples (data not shown).
DISCUSSION
Several previous studies have described the development of
specific PCR techniques for the detection of C. albicans and
assessed their sensitivity in vitro and in vivo. Buchman et al.
(3), Miyakawa et al. (10), and Holmes et al. (5) were able to
detect610 Candida cells per 100 ml of 1 ml of blood. Buchman
et al. (3), Kahn (8), and Crampin and Matthews (4) were able
FIG. 3. Progression of systemic infection in neutropenic mice, expressed as
the mean number of CFU of C. albicans in the kidney (1), spleen (E), lung (),
and liver (}), obtained from three separate in vivo experiments. In each exper-
iment, 21 mice were inoculated with 104 CFU of C. albicans and three mice were
sacrificed at 1, 6, 24, 48, 72, 96, and 144 h after i.v. inoculation. Each symbol
represents the geometric mean, 6 the standard deviation, for three experiments
using three mice each (n 5 9).
FIG. 4. Southern blot analysis of Candida PCR amplificates from the blood
of each mouse with systemic candidiasis sacrificed at the indicated time intervals.
Lanes: 1 to 3, 4 to 6, 7 to 9, 10 to 12, 13 to 15, 16 and 17, and 18 represent mice
sacrificed at 1, 6, 24, 48, 72, 96, and 144 h after i.v. inoculation, respectively. 1,
positive controls;2, negative controls (processed blood of uninfected mice). The
top gel corresponds to experiment 1, and the bottom gel corresponds to exper-
iment 3 (Table 1).
TABLE 1. Individual blood culture and PCR results obtained from neutropenic mice sacrificed at the indicated times
after i.v. inoculation with C. albicans, in each of three separate experiments
Time (h)
Resultsa for expt: Sensitivity (%)b
1 2 3
Culture PCR
No. of CFUc PCRd No. of CFU PCR No. of CFU PCR
1 39, 7, 6 1, 1, 1 9, 12, 2 1, 1, 1 6, 3, 5 1, 1, 1 100 100
6 6, 1, 3 1, 1, 1 3, 3, 4 1, 1, 1 0, 3, 0 1, 1, 1 78 100
24 1, 0, 0 1, 1, 1 3, 1, 1 1, 2, 1 8, 4, 0 1, 1, 1 67 89
48 2, 0, 0 1, 1, 1 0, 0, 0 1, 1, 2 20, 7, 1 1, 1, 1 44 89
72 0, 0, 0 1, 1, 1 27, 15, 13 1, 1, 1 34, 45, 14 1, 1, 1 67 100
96 0, 0, —e 1, 1, — —, —, — —, —, — 5, 1, — 1, 1, — 50 100
144 1, —, — 1, —, — —, —, — —, —, — —, —, — —, —, — 100 100
a Each result is for a single mouse (three mice per experiment).
b Sensitivities were determined presuming all samples should be culture and PCR positive.
c Per 100 ml of blood collected in EDTA-coated tubes.
d Using 25 ml of pretreated blood.
eMouse died prematurely.
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to detect C. albicans not only in blood samples but also in other
clinical specimens including sputum and urine. However, since
these specimens were usually positive by conventional culture
as well, PCR did not contribute much to the actual diagnostic
sensitivity. Furthermore, most assays described were too spe-
cific, in the sense that they were designed to detect C. albicans
only.
The PCRmethod described in this paper uses primers aimed
at the multicopy gene coding for the small subunit rRNA and
results in a 180-bp fragment. The advantage is that with the use
of a species-specific probe both yeast genus- and species-spe-
cific information can be obtained by a single PCR (13). To
study the merits of this PCR method, its sensitivity and spec-
ificity were tested in neutropenic mice with an induced sys-
temic infection and in immunocompetent mice with gastroin-
testinal colonization only. The sensitivity of this PCR method
is on the order of 10 to 15 C. albicans cells per 100 ml of spiked
blood, which is comparable to the results of other methods (3,
5, 10). We also demonstrated that the digestion of non-yeast
DNA is essential for obtaining such levels of sensitivity. Omit-
ting the DNase pretreatment procedure reduces the sensitivity
by at least a factor of 10 and may also result in aspecific
amplificates, as was shown by Crampin and Matthews (4),
although they used another primer set aimed at the HSP 90
protein. Other parameters for increasing the sensitivity, like
concentrations of MgCl2, dNTPs, and primers, have been op-
timized as described previously (13). Furthermore, it has been
demonstrated that the storage conditions of blood samples
influence the sensitivity and reproducibility of the PCR assay.
We did not succeed in clarifying the negative effect of freezing,
since by microscopy Candida cells looked intact and were still
viable when checked by culture. Possibly, the Candida cells
become fragile during freezing and thawing such that the
DNase, during the pretreatment step, can reach some of the
essential Candida target DNA, thereby reducing the sensitivity
and reproducibility of the PCR assay.
For the neutropenic mice with a systemic Candida infection,
a higher percentage of positive test results was obtained by
PCR than was obtained by conventional blood culture. Kahn
(8) also demonstrated positive PCR results with a candidemic
murine model. However, in that study, blood samples obtained
from five mice were pooled and were always positive by cul-
ture. In contrast, we demonstrated positive PCR results from
blood samples of individual mice, some of which had sterile
blood cultures at the same time. Positive PCR results may be
due to the amplification of circulating nonviable Candida cells,
e.g., those within phagocytic cells. It is this aspect of the PCR
technique which makes the method more sensitive than blood
culture. Makimura et al. (9) also obtained positive PCR results
from culture-positive as well as culture-negative blood samples
of mice infected with C. albicans. However, for DNA extrac-
tion they used a volume of blood which was twice that used for
culture. Since the sensitivity of an assay is influenced by the
volume tested, their results should be interpreted with great
care. In our study we actually applied only 25 ml of blood for
PCR compared with 100 ml for blood culture. Thus, the sen-
sitivity of our PCR method may be further increased by using
more target DNA in the final reaction. Despite the sensitivity
of the PCR, PCR results obtained from blood samples of
gastrointestinally colonized mice were always negative. This
particular aspect makes this PCR method useful since it is able
to discriminate between invasive candidiasis and colonization.
The negative findings with the colonized model also underline
the target specificity of this PCR method, in that no false-
positive results were obtained because of existing normal
mouse bacterial flora.
Although the PCR assay of blood samples of mice with
systemic candidiasis was not designed to give quantitative in-
formation, the intensity of the hybridization signal clearly in-
creased with the progression of the infection. These findings
suggest a correlation between the PCR results and the degree
of dissemination of infection and make the technique possibly
valuable as a clinical monitoring assay.
In conclusion, PCR with primers directed against the small
subunit rRNA gene in combination with the C. albicans-
specific probe provided a sensitive and specific assay for de-
tecting Candida DNA in whole blood. This PCR method
promises to be more sensitive than blood culture and may be
an adequate technique in the early detection and follow-up of
invasive candidiasis. Besides being sensitive, this PCR is spe-
cific, since PCR results obtained from blood samples of gas-
trointestinally colonized mice were negative; therefore, this
PCR is diagnostically useful. Another positive diagnostic con-
tribution is the relative speed of the PCR, since results are
achieved within 2 days, whereas conventional blood cultures
take 1 to 7 days or even longer. The true clinical relevance and
utility of this test has to be proven in a prospective clinical
study in which conventional blood cultures are evaluated in
relation to PCR.
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